Kannaway provides high quality, triple tested CBD products. We are currently only doing business in the United States but we are in the Pre-Launch phase in the European Union. We will Launch in all 28 European Union countries in November 2017.
Cannabidiol or CBD is a non-intoxicating component of the cannabis plant with enormous therapeutic potential. Although CBD doesn’t make people feel high like THCdoes, it’s causing quite a buzz among scientists, health professionals, and medical marijuana patients who are using CBD-rich products to treat a wide range of conditions—chronic pain, cancer, Crohn’s, diabetes, rheumatoid arthritis, PTSD, cardiovascular disease, anxiety, antibiotic-resistant infections, multiple sclerosis, schizophrenia, and more.
Our company needs more high quality leadership
I extend to you my personal invitation to review the company in this webinar
Complete the form below if you would like to learn more about the Kannaway opportunity or products